Luohe Nanjiecun Pharma was invited to participate in the 2019 CPhI India.
On November 26-28, 2019, our company was invited to participate in 2019 CPhI India.
On November 26-28, 2019, our company was invited to participate in 2019 CPhI India.
On November 5-7, 2019, our company was invited to participate in 2019 CPhI Worldwide Europe.
October 10-12, 2019, our company was invited to participate in the 83th API China
June 18-20, 2019, our company was invited to participate in the 2019 CPhI China.
May 8-10, 2019, our company was invited to participate in the 82th API China.
Rifabutin is an antibiotic that fights bacteria. Generic Name: rifabutin (RIF a BUE tin)Brand Name: Mycobutin Rifabutin is used to prevent mycobacterium avium complex (MAC) in people with HIV (human immunodeficiency virus) infection. Rifabutin is also used with other medicines to treat tuberculosis in people with HIV. Rifabutin may also be used for purposes not listed in this medication guide. Mycobacterium avium complex …
China has expanded to be the second largest pharmaceutical market globally with USD 137 billion in total spending in 2018, but growth has slowed from a 19% CAGR in 2008–2013 to an 8% CAGR in 2013–2018 and is expected to continue to decline to 3-6% through 2023, as the below charts show. Much of China’s growth …
The bacteria that cause tuberculosis (TB) can develop resistance to the antimicrobial drugs used to cure the disease. Multidrug-resistant TB (MDR-TB) is TB that does not respond to at least isoniazid and rifampicin, the 2 most powerful anti-TB drugs. The 2 reasons why multidrug resistance continues to emerge and spread are mismanagement of TB treatment …
What is multidrug-resistant tuberculosis and how do we control it? Read More »
Rifaximin, an antibiotic used to treat Travelers Diarrhea, Irritable Bowel Syndrome, and Hepatic Encephalopathy. Traveller Diarrhea Traveler diarrhea is a gastrointestinal infection. Rifaximin, as an antibiotic and not easily absorbed by the intestine, is widely used to treat the disease. Irritable bowel syndrome Rifaximin is approved in the United States for the treatment of irritable bowel …
China is the world’s largest exporter and importer of APIs. Our country’s APIs occupy an irreplaceable position in the global market. Among them, the bulk of APIs are mainly exported. The production of APIs has brought economic benefits to China, but at the same time, the environmental problems caused by the production process cannot be ignored. …